Jenburkt Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
326.05 Cr.
|
P/BV
|
2.66
|
Book Value (Rs.)
|
277.32
|
52 Week High/Low (Rs.)
|
925/587
|
FV/ML
|
10/1
|
P/E(X)
|
13.25
|
Bookclosure
|
26/07/2023
|
EPS (Rs.)
|
55.76
|
Div Yield (%)
|
1.95
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 53.90 | 48.58 | 35.96 | 32.40 | 43.14 |
Diluted EPS (Rs.) | 53.90 | 48.58 | 35.96 | 32.40 | 43.14 |
Cash EPS (Rs.) | 60.88 | 52.72 | 40.39 | 37.41 | 46.09 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 277.32 | 255.77 | 214.55 | 174.32 | 168.79 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 277.32 | 255.77 | 214.55 | 174.32 | 168.79 |
Dividend / Share (Rs.) | 14.40 | 12.00 | 10.20 | 8.10 | 10.20 |
Revenue From Operations / Share (Rs.) | 309.86 | 270.14 | 238.14 | 259.06 | 267.23 |
PBDIT / Share (Rs.) | 80.42 | 70.17 | 52.62 | 52.21 | 61.82 |
PBIT / Share (Rs.) | 75.30 | 66.03 | 48.19 | 47.20 | 58.87 |
PBT / Share (Rs.) | 74.47 | 65.09 | 47.16 | 46.06 | 58.03 |
Net Profit / Share (Rs.) | 55.76 | 48.58 | 35.96 | 32.40 | 43.14 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 25.95 | 25.97 | 22.09 | 20.15 | 23.13 |
PBIT Margin (%) | 24.30 | 24.44 | 20.23 | 18.22 | 22.03 |
PBT Margin (%) | 24.03 | 24.09 | 19.80 | 17.77 | 21.71 |
Net Profit Margin (%) | 17.99 | 17.98 | 15.09 | 12.50 | 16.14 |
Return on Networth / Equity (%) | 20.10 | 18.99 | 16.75 | 18.58 | 25.55 |
Return on Capital Employeed (%) | 26.36 | 24.90 | 21.58 | 25.70 | 33.68 |
Return On Assets (%) | 17.35 | 15.59 | 13.70 | 14.28 | 19.25 |
Total Debt / Equity (X) | 0.01 | 0.04 | 0.03 | 0.04 | 0.09 |
Asset Turnover Ratio (%) | 0.96 | 0.94 | 0.97 | 1.15 | 1.36 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 5.14 | 3.57 | 4.46 | 4.52 | 3.96 |
Quick Ratio (X) | 4.62 | 3.10 | 4.04 | 3.97 | 3.53 |
Inventory Turnover Ratio (X) | 1.22 | 1.34 | 0.73 | 0.93 | 1.42 |
Dividend Payout Ratio (NP) (%) | 22.38 | 20.99 | 0.00 | 68.09 | 16.76 |
Dividend Payout Ratio (CP) (%) | 20.49 | 19.34 | 0.00 | 58.97 | 15.69 |
Earning Retention Ratio (%) | 77.62 | 79.01 | 0.00 | 31.91 | 83.24 |
Cash Earning Retention Ratio (%) | 79.51 | 80.66 | 0.00 | 41.03 | 84.31 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 96.71 | 74.13 | 50.98 | 45.59 | 73.52 |
Interest Coverage Ratio (Post Tax) (%) | 68.05 | 52.33 | 35.84 | 29.29 | 52.30 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 242.56 | 216.85 | 130.05 | 91.62 | 187.63 |
EV / Net Operating Revenue (X) | 1.77 | 1.75 | 1.19 | 0.77 | 1.53 |
EV / EBITDA (X) | 6.83 | 6.73 | 5.38 | 3.82 | 6.61 |
MarketCap / Net Operating Revenue (X) | 2.15 | 2.10 | 1.67 | 1.23 | 1.89 |
Retention Ratios (%) | 77.61 | 79.00 | 0.00 | 31.90 | 83.23 |
Price / BV (X) | 2.40 | 2.22 | 1.86 | 1.82 | 2.99 |
Price / Net Operating Revenue (X) | 2.15 | 2.10 | 1.67 | 1.23 | 1.89 |
EarningsYield | 0.08 | 0.08 | 0.09 | 0.10 | 0.08 |